These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 32016681
61. Generic and disease-specific estimates of quality of life in macular degeneration: mapping the MacDQoL onto the EQ-5D-3L. Dixon P, Dakin H, Wordsworth S. Qual Life Res; 2016 Apr; 25(4):935-45. PubMed ID: 26462812 [Abstract] [Full Text] [Related]
62. An exploratory study to test the impact on three "bolt-on" items to the EQ-5D. Yang Y, Rowen D, Brazier J, Tsuchiya A, Young T, Longworth L. Value Health; 2015 Jan; 18(1):52-60. PubMed ID: 25595234 [Abstract] [Full Text] [Related]
65. EQ-5D Brazilian population norms. Santos M, Monteiro AL, Santos B. Health Qual Life Outcomes; 2021 Jun 10; 19(1):162. PubMed ID: 34112207 [Abstract] [Full Text] [Related]
68. Comparing and transforming PROMIS utility values to the EQ-5D. Hartman JD, Craig BM. Qual Life Res; 2018 Mar 10; 27(3):725-733. PubMed ID: 29264776 [Abstract] [Full Text] [Related]
70. General population reference values for 3-level EQ-5D (EQ-5D-3L) questionnaire in Poland. Golicki D, Niewada M. Pol Arch Med Wewn; 2015 Mar 10; 125(1-2):18-26. PubMed ID: 25578383 [Abstract] [Full Text] [Related]
71. EQ-5D-3L as a health measure of Brazilian adult population. Menezes Rde M, Andrade MV, Noronha KV, Kind P. Qual Life Res; 2015 Nov 10; 24(11):2761-76. PubMed ID: 25896666 [Abstract] [Full Text] [Related]
72. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method. Kharroubi SA, O'Hagan A, Brazier JE. Stat Med; 2010 Jul 10; 29(15):1622-34. PubMed ID: 20209481 [Abstract] [Full Text] [Related]
73. Mapping EQ-5D-3L to EQ-5D-5L. van Hout BA, Shaw JW. Value Health; 2021 Sep 10; 24(9):1285-1293. PubMed ID: 34452708 [Abstract] [Full Text] [Related]
75. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model. Franken MD, de Hond A, Degeling K, Punt CJA, Koopman M, Uyl-de Groot CA, Versteegh MM, van Oijen MGH. Health Qual Life Outcomes; 2020 Jul 20; 18(1):240. PubMed ID: 32690011 [Abstract] [Full Text] [Related]
76. Mapping EQ-5D-3L from the Knee Injury and Osteoarthritis Outcome Score (KOOS). Kiadaliri A, Alava MH, Roos EM, Englund M. Qual Life Res; 2020 Jan 20; 29(1):265-274. PubMed ID: 31541386 [Abstract] [Full Text] [Related]
78. Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data. Ramos-Goñi JM, Oppe M, Estévez-Carrillo A, Rivero-Arias O, IMPACT HTA HRQoL Group. Value Health; 2022 May 20; 25(5):835-843. PubMed ID: 35500952 [Abstract] [Full Text] [Related]
79. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey. Jankowska A, Młyńczak K, Golicki D. Health Qual Life Outcomes; 2021 May 05; 19(1):138. PubMed ID: 33952271 [Abstract] [Full Text] [Related]